1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. XILIO THERAPEUTICS INC
Xilio Therapeutics Inc
XNAS: XLO
7.60 0.17 (2.29%)
30,146
XNAS Volume

XNAS 18 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The latest board meeting for Xilio Therapeutics Inc took place on 18 Mar 2026, for the purpose of Xilio Therapeutics Inc Annual Report for 2025 See details

Xilio Therapeutics Inc - XLO - stock price prediction, stock price target, analyst ratings from 1 analyst

Xilio Therapeutics Inc has a share price target of , revenue growth forecast of 620.0%, and profit growth estimate of 26.0% for FY25, based on top 1 analyst call.